Table 1.

Reported symptoms in 65 patients with DPPX antibody-associated encephalitis^{*) **)}.

Symptoms	Number of patients with symptom (%)	Female/male
Gastrointestinal symptoms and/or weight loss	47 (72 %)	15/31***)
Cognitive dysfunction	56 (86 %)	18/37***)
Psychiatric symptoms	24 (37 %)	12/12
CNS hyperexcitability (myoclonus, tremor, hyperreflexia seizures)	49 (75 %)	13/35***)
Paresis	1 (2 %)	1/0
Cerebellar dysfunction	29 (45 %)	12/17
Brain stem disorders	16 (25 %)	5/11
Dysautonomia	19 (29 %)	5/11****)
Sleep disorders	26 (40 %)	11/15
Sensory symptoms (allodynia, pruritus)	5 (8%)	0/5

^*)Based on the following studies 1, 2, 5–23.

^**)Details given in Supplementary Table S1.

^***)Gender not reported for one patient.

^****)Gender not reported for three patients.